MODERNA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.2 USD | -2.00% |
|
-4.30% | +20.29% |
| 03:17pm | Sector Update: Health Care Stocks Edge Higher Premarket Friday | MT |
| 02:54pm | Moderna's RSV Vaccine Review Delayed by FDA to End of May | MT |
ETFs positioned on Moderna, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.20% | 0 M€ | +3.88% | - | |
| 0.20% | 330 M€ | -.--% | - | |
| 0.19% | 6 M€ | +17.98% | - | |
| 0.18% | 0 M€ | +7.07% | - | |
| 0.17% | 0 M€ | -.--% | - | |
| 0.17% | 0 M€ | +4.60% | - | |
| 0.17% | 0 M€ | +8.70% | ||
| 0.16% | 0 M€ | +18.44% | - | |
| 0.16% | 0 M€ | +8.31% | ||
| 0.15% | 0 M€ | +9.59% | ||
| 0.15% | 0 M€ | +12.42% | - | |
| 0.14% | 559 M€ | +14.30% | - | |
| 0.14% | 1,848 M€ | +18.39% | - | |
| 0.13% | 0 M€ | +6.12% | - | |
| 0.12% | 0 M€ | +19.88% | - | |
| 0.11% | 1,174 M€ | +23.54% | ||
| 0.11% | 273 M€ | -.--% | ||
| 0.11% | 655 M€ | -.--% | - | |
| 0.11% | 0 M€ | +9.11% | - | |
| 0.11% | 1 M€ | -.--% | ||
| 0.10% | 0 M€ | +18.92% | ||
| 0.09% | 0 M€ | +11.62% | - | |
| 0.09% | 0 M€ | +8.93% |
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
122.7
USD
Average target price
139.4
USD
Spread / Average Target
+13.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.29% | 47.02B | |
| +49.28% | 41.86B | |
| +0.16% | 41.76B | |
| -4.27% | 28.8B | |
| +11.82% | 26.05B | |
| -22.03% | 19.15B | |
| +4.42% | 12.55B | |
| +28.84% | 12.34B | |
| -4.79% | 11.82B | |
| +20.97% | 11.8B |
- Stock Market
- Equities
- MRNA Stock
- Funds and ETFs Moderna, Inc.